Linux Laboratories
Cerebroprotein Hydrolysate (60mg)
Cogniza 60mg Injection is a prescription medicine used in the treatment of stroke, head injury, and Alzheimer's disease.
Injection
Cogniza 60mg Injection is a prescription medicine used in the treatment of stroke, head injury, and Alzheimer's disease. It may be used alone or in combination with other medicines, depending on the illness it is being used for.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Nausea headache and vertigo may occur.
It is not known whether it is safe to consume alcohol with Cogniza 60mg Injection. Please consult your doctor.
Information regarding the use of Cogniza 60mg Injection during breastfeeding is not available. Please consult your doctor.
Information regarding the use of Cogniza 60mg Injection during pregnancy is not available. Please consult your doctor.
Cogniza 60mg Injection is a nerve repairing medicine. It works on the brain by repairing the nerve cells and improves their survival.
Do not take in case of epilepsy and severe kidney problem. Let your doctor know if you are pregnant or planning for pregnancy.
Cerebroprotein hydrolysate is a medical extract derived from porcine brain tissue that plays a role in protecting nerves and enhancing brain function within the central nervous system.
It is administered via injection under the direct supervision of a healthcare professional, typically over a period of 15 minutes. The duration may vary depending on the specific dosage and route of administration prescribed by the doctor.
Cogniza 60mg Injection can be administered either intramuscularly (into a muscle) or intravenously (into a vein), as directed by the healthcare professional based on the patient's condition and specific treatment needs.
The effectiveness of Cogniza 60mg Injection may be observed after approximately two weeks of treatment, although this timeframe can vary depending on individual factors such as the patient's underlying condition, response to treatment, and dosage administered.
The recommended course of treatment typically spans 10-20 days of continuous daily usage of the prescribed dosage. However, this may be adjusted based on factors such as the patient's age and specific medical needs.
While there is currently no evidence to suggest that Cogniza 60mg Injection causes further kidney problems, it should not be administered to individuals with severe kidney disease. Consultation with a healthcare professional is necessary for patients with pre-existing kidney issues.
Given that Cogniza 60mg Injection is typically administered by a qualified healthcare professional in a hospital setting, the risk of an overdose is extremely low. However, if an overdose is suspected or confirmed, emergency medical treatment will be promptly initiated to address any adverse effects.